Equity Capital Markets

Company · CIK 1645108

MDNA Life Sciences, Inc.

CIK1645108 (SEC EDGAR)
Industry (SIC)2835 — In Vitro & In Vivo Diagnostic Substances
Incorporated inDE
Business addressFL
Listedno ticker on SEC record today
First annual or quarterly reportnone on EDGAR

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-266613
First-time registrationDormant
 2022-08-052023-05-0917

Filings

18
FiledFilingRegistrationAccession
2023-05-09S-1/AAmendment 333-2666130001575872-23-000687
2023-05-02S-1/AAmendment 333-2666130001575872-23-000658
2023-04-25S-1/AAmendment 333-2666130001575872-23-000617
2023-04-21S-1/AAmendment 333-2666130001575872-23-000584
2023-04-17S-1/AAmendment 333-2666130001575872-23-000566
2023-04-12S-1/AAmendment 333-2666130001575872-23-000552
2023-04-11S-1/AAmendment 333-2666130001575872-23-000543
2023-04-06S-1/AAmendment 333-2666130001575872-23-000520
2023-04-03S-1/AAmendment 333-2666130001575872-23-000500
2023-03-31S-1/AAmendment 333-2666130001575872-23-000480
2023-03-28S-1/AAmendment 333-2666130001575872-23-000460
2023-03-16S-1/AAmendment 333-2666130001575872-23-000370
2023-02-10S-1/AAmendment 333-2666130001575872-23-000248
2023-01-30S-1/AAmendment 333-2666130001575872-23-000178
2022-11-07S-1/AAmendment 333-2666130001575872-22-001072
2022-10-21S-1/AAmendment 333-2666130001575872-22-001001
2022-08-05S-1Registration filed 333-2666130001575872-22-000722
2022-04-11DRSDraft made public 377-061270001575872-22-000261

All filings of this company · CSV